Skip to main content
. Author manuscript; available in PMC: 2014 Sep 8.
Published in final edited form as: Open J Endocr Metab Dis. 2013 May 23;3(2):103–112. doi: 10.4236/ojemd.2013.32016

Figure 1.

Figure 1

Unadjusted prevalence of rapid decline among MESA participants with GFR > 60 mL/min/1.73m2 estimated by creatinine (Cr) and cystatin C (Cys). (a) Body mass index; (b) Waist circumference and waist to hip ratio.